Rationale and design of the pullback pressure gradient (PPG) global registry
Copyright © 2023 Elsevier Inc. All rights reserved..
INTRODUCTION: Diffuse disease has been identified as one of the main reasons leading to low post-PCI fractional flow reserve (FFR) and residual angina after PCI. Coronary pressure pullbacks allow for the evaluation of hemodynamic coronary artery disease (CAD) patterns. The pullback pressure gradient (PPG) is a novel metric that quantifies the distribution and magnitude of pressure losses along the coronary artery in a focal-to-diffuse continuum.
AIM: The primary objective is to determine the predictive capacity of the PPG for post-PCI FFR.
METHODS: This prospective, large-scale, controlled, investigator-initiated, multicenter study is enrolling patients with at least 1 lesion in a major epicardial vessel with a distal FFR ≤ 0.80 intended to be treated by PCI. The study will include 982 subjects. A standardized physiological assessment will be performed pre-PCI, including the online calculation of PPG from FFR pullbacks performed manually. PPG quantifies the CAD pattern by combining several parameters from the FFR pullback curve. Post-PCI physiology will be recorded using a standardized protocol with FFR pullbacks. We hypothesize that PPG will predict optimal PCI results (post-PCI FFR ≥ 0.88) with an area under the ROC curve (AUC) ≥ 0.80. Secondary objectives include patient-reported and clinical outcomes in patients with focal vs. diffuse CAD defined by the PPG. Clinical follow-up will be collected for up to 36 months, and an independent clinical event committee will adjudicate events.
RESULTS: Recruitment is ongoing and is expected to be completed in the second half of 2023.
CONCLUSION: This international, large-scale, prospective study with pre-specified powered hypotheses will determine the ability of the preprocedural PPG index to predict optimal revascularization assessed by post-PCI FFR. In addition, it will evaluate the impact of PPG on treatment decisions and the predictive performance of PPG for angina relief and clinical outcomes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:265 |
---|---|
Enthalten in: |
American heart journal - 265(2023) vom: 25. Nov., Seite 170-179 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Munhoz, Daniel [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 12.10.2023 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.ahj.2023.07.016 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361102941 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361102941 | ||
003 | DE-627 | ||
005 | 20231226084432.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ahj.2023.07.016 |2 doi | |
028 | 5 | 2 | |a pubmed24n1203.xml |
035 | |a (DE-627)NLM361102941 | ||
035 | |a (NLM)37611857 | ||
035 | |a (PII)S0002-8703(23)00205-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Munhoz, Daniel |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rationale and design of the pullback pressure gradient (PPG) global registry |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a INTRODUCTION: Diffuse disease has been identified as one of the main reasons leading to low post-PCI fractional flow reserve (FFR) and residual angina after PCI. Coronary pressure pullbacks allow for the evaluation of hemodynamic coronary artery disease (CAD) patterns. The pullback pressure gradient (PPG) is a novel metric that quantifies the distribution and magnitude of pressure losses along the coronary artery in a focal-to-diffuse continuum | ||
520 | |a AIM: The primary objective is to determine the predictive capacity of the PPG for post-PCI FFR | ||
520 | |a METHODS: This prospective, large-scale, controlled, investigator-initiated, multicenter study is enrolling patients with at least 1 lesion in a major epicardial vessel with a distal FFR ≤ 0.80 intended to be treated by PCI. The study will include 982 subjects. A standardized physiological assessment will be performed pre-PCI, including the online calculation of PPG from FFR pullbacks performed manually. PPG quantifies the CAD pattern by combining several parameters from the FFR pullback curve. Post-PCI physiology will be recorded using a standardized protocol with FFR pullbacks. We hypothesize that PPG will predict optimal PCI results (post-PCI FFR ≥ 0.88) with an area under the ROC curve (AUC) ≥ 0.80. Secondary objectives include patient-reported and clinical outcomes in patients with focal vs. diffuse CAD defined by the PPG. Clinical follow-up will be collected for up to 36 months, and an independent clinical event committee will adjudicate events | ||
520 | |a RESULTS: Recruitment is ongoing and is expected to be completed in the second half of 2023 | ||
520 | |a CONCLUSION: This international, large-scale, prospective study with pre-specified powered hypotheses will determine the ability of the preprocedural PPG index to predict optimal revascularization assessed by post-PCI FFR. In addition, it will evaluate the impact of PPG on treatment decisions and the predictive performance of PPG for angina relief and clinical outcomes | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Collet, Carlos |e verfasserin |4 aut | |
700 | 1 | |a Mizukami, Takuya |e verfasserin |4 aut | |
700 | 1 | |a Yong, Andy |e verfasserin |4 aut | |
700 | 1 | |a Leone, Antonio Maria |e verfasserin |4 aut | |
700 | 1 | |a Eftekhari, Ashkan |e verfasserin |4 aut | |
700 | 1 | |a Ko, Brian |e verfasserin |4 aut | |
700 | 1 | |a da Costa, Bruno R |e verfasserin |4 aut | |
700 | 1 | |a Berry, Colin |e verfasserin |4 aut | |
700 | 1 | |a Collison, Damien |e verfasserin |4 aut | |
700 | 1 | |a Perera, Divaka |e verfasserin |4 aut | |
700 | 1 | |a Christiansen, Evald Høj |e verfasserin |4 aut | |
700 | 1 | |a Rivero, Fernando |e verfasserin |4 aut | |
700 | 1 | |a Zimmermann, Frederik M |e verfasserin |4 aut | |
700 | 1 | |a Ando, Hirohiko |e verfasserin |4 aut | |
700 | 1 | |a Matsuo, Hitoshi |e verfasserin |4 aut | |
700 | 1 | |a Nakayama, Masafumi |e verfasserin |4 aut | |
700 | 1 | |a Escaned, Javier |e verfasserin |4 aut | |
700 | 1 | |a Sonck, Jeroen |e verfasserin |4 aut | |
700 | 1 | |a Sakai, Koshiro |e verfasserin |4 aut | |
700 | 1 | |a Adjedj, Julien |e verfasserin |4 aut | |
700 | 1 | |a Desta, Liyew |e verfasserin |4 aut | |
700 | 1 | |a van Nunen, Lokien X |e verfasserin |4 aut | |
700 | 1 | |a West, Nick E J |e verfasserin |4 aut | |
700 | 1 | |a Fournier, Stephane |e verfasserin |4 aut | |
700 | 1 | |a Storozhenko, Tatyana |e verfasserin |4 aut | |
700 | 1 | |a Amano, Tetsuya |e verfasserin |4 aut | |
700 | 1 | |a Engstrøm, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Johnson, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Shinke, Toshiro |e verfasserin |4 aut | |
700 | 1 | |a Biscaglia, Simone |e verfasserin |4 aut | |
700 | 1 | |a Fearon, William F |e verfasserin |4 aut | |
700 | 1 | |a Ali, Ziad |e verfasserin |4 aut | |
700 | 1 | |a De Bruyne, Bernard |e verfasserin |4 aut | |
700 | 1 | |a Johnson, Nils P |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American heart journal |d 1945 |g 265(2023) vom: 25. Nov., Seite 170-179 |w (DE-627)NLM000012270 |x 1097-6744 |7 nnns |
773 | 1 | 8 | |g volume:265 |g year:2023 |g day:25 |g month:11 |g pages:170-179 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ahj.2023.07.016 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 265 |j 2023 |b 25 |c 11 |h 170-179 |